PT98905A - Processo para a preparacao de mono-hidrato de furoato de mometasona,e de composicoes farmaceuticas que o contem - Google Patents

Processo para a preparacao de mono-hidrato de furoato de mometasona,e de composicoes farmaceuticas que o contem

Info

Publication number
PT98905A
PT98905A PT98905A PT9890591A PT98905A PT 98905 A PT98905 A PT 98905A PT 98905 A PT98905 A PT 98905A PT 9890591 A PT9890591 A PT 9890591A PT 98905 A PT98905 A PT 98905A
Authority
PT
Portugal
Prior art keywords
preparation
pharmaceutical compositions
compositions containing
momethanone
furoate monohydrate
Prior art date
Application number
PT98905A
Other languages
English (en)
Other versions
PT98905B (pt
Inventor
Pui-Ho Yuen
Charles Eckhart
Teresa Etlinger
Nancy Levine
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24320279&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT98905(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Corp filed Critical Schering Corp
Publication of PT98905A publication Critical patent/PT98905A/pt
Publication of PT98905B publication Critical patent/PT98905B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
PT98905A 1990-09-10 1991-09-09 Processo para a preparacao de mono-hidrato de furoato de mometasona,e de composicoes farmaceuticas que o contem PT98905B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US58023990A 1990-09-10 1990-09-10

Publications (2)

Publication Number Publication Date
PT98905A true PT98905A (pt) 1992-09-30
PT98905B PT98905B (pt) 1998-08-31

Family

ID=24320279

Family Applications (1)

Application Number Title Priority Date Filing Date
PT98905A PT98905B (pt) 1990-09-10 1991-09-09 Processo para a preparacao de mono-hidrato de furoato de mometasona,e de composicoes farmaceuticas que o contem

Country Status (35)

Country Link
US (1) US6180781B1 (pt)
EP (1) EP0548114B1 (pt)
JP (1) JPH0725789B2 (pt)
KR (1) KR960013445B1 (pt)
CN (1) CN1030920C (pt)
AT (1) ATE113604T1 (pt)
AU (1) AU663471B2 (pt)
BG (1) BG60755B2 (pt)
CA (1) CA2091360C (pt)
CZ (1) CZ281318B6 (pt)
DE (2) DE69104991T2 (pt)
DK (1) DK0548114T5 (pt)
EE (1) EE02962B1 (pt)
ES (1) ES2065701T3 (pt)
FI (1) FI111078B (pt)
HK (1) HK185996A (pt)
HR (1) HRP920383B1 (pt)
HU (1) HU213401B (pt)
IE (1) IE67056B1 (pt)
IL (1) IL99437A (pt)
LU (1) LU90366I2 (pt)
MX (2) MX9203396A (pt)
MY (1) MY106644A (pt)
NL (1) NL980012I2 (pt)
NO (1) NO300548B1 (pt)
NZ (1) NZ239711A (pt)
OA (1) OA09772A (pt)
PH (1) PH30443A (pt)
PL (1) PL165803B1 (pt)
PT (1) PT98905B (pt)
SI (1) SI9111497A (pt)
TW (2) TW272195B (pt)
WO (1) WO1992004365A1 (pt)
YU (1) YU48666B (pt)
ZA (1) ZA917148B (pt)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL165803B1 (pl) * 1990-09-10 1995-02-28 Schering Corp Sposób wytwarzania nowego monohydratu 9a, 21-dichloro-16-a metylo-1,4-pregnadieno-11 ß , 17a-diolo-3,20-diono-17-(2’furanokarboksylanu) PL PL PL PL
PE44995A1 (es) * 1994-01-27 1995-12-18 Schering Corp Furoato de mometasona para el tratamiento de las enfermedades pulmonares y de las vias respiratorias
US5837699A (en) 1994-01-27 1998-11-17 Schering Corporation Use of mometasone furoate for treating upper airway passage diseases
US5886200A (en) * 1996-07-01 1999-03-23 Schering Corporation Process for the preparation of 17-esters of 9 α, 21-dihalo-pregnane-11 β, 17 α-diol-20-ones
US5976573A (en) 1996-07-03 1999-11-02 Rorer Pharmaceutical Products Inc. Aqueous-based pharmaceutical composition
CN1059476C (zh) * 1996-08-21 2000-12-13 邓维鹏 金黄色铝合金硒盐电解着色方法
DE69804998T2 (de) * 1997-10-09 2002-12-12 Schering Corp., Kenilworth Mometasonfuroat-suspensionen zum zerstäuben
US6187765B1 (en) * 1997-10-09 2001-02-13 Schering Corporation Mometasone furoate suspensions for nebulization
MY133181A (en) * 1998-09-10 2007-10-31 Schering Corp Methods and compositions for treating sinusitis, otitis media and other related disorders using antihistamines
CZ20013912A3 (cs) 1999-05-04 2002-05-15 Strakan Limited Androgen glykosid, sloučenina, testosteron-ß-D-glukosid, 5 alfa-Dihydrotestosteron- 17ß-D-glukosid, farmaceutický prostředek a pouľití sloučeniny
GB0207906D0 (en) * 2002-04-05 2002-05-15 3M Innovative Properties Co Formoterol and mometasone aerosol formulations
US9808471B2 (en) 2003-04-16 2017-11-07 Mylan Specialty Lp Nasal pharmaceutical formulations and methods of using the same
US8912174B2 (en) 2003-04-16 2014-12-16 Mylan Pharmaceuticals Inc. Formulations and methods for treating rhinosinusitis
US7811606B2 (en) 2003-04-16 2010-10-12 Dey, L.P. Nasal pharmaceutical formulations and methods of using the same
US7825147B2 (en) * 2003-08-29 2010-11-02 Ranbaxy Laboratories Limited Inhibitors of phosphodiesterase type-IV
US20070259874A1 (en) * 2003-11-26 2007-11-08 Palle Venkata P Phosphodiesterase Inhibitors
US7491725B2 (en) 2004-02-06 2009-02-17 Bristol-Myers Squibb Company Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors
US7915286B2 (en) 2005-09-16 2011-03-29 Ranbaxy Laboratories Limited Substituted pyrazolo [3,4-b] pyridines as phosphodiesterase inhibitors
US20070099883A1 (en) * 2005-10-07 2007-05-03 Cheryl Lynn Calis Anhydrous mometasone furoate formulation
WO2007045979A1 (en) 2005-10-19 2007-04-26 Ranbaxy Laboratories Limited Pharmaceutical compositions of muscarinic receptor antagonists
CA2626628A1 (en) * 2005-10-19 2007-04-26 Ranbaxy Laboratories Limited Compositions of phosphodiesterase type iv inhibitors
CN100436473C (zh) * 2005-12-09 2008-11-26 天津药业集团有限公司 糠酸莫美他松中间体21-酯及制法
CN100389121C (zh) * 2005-12-09 2008-05-21 天津药业集团有限公司 糠酸莫美他松中间体21-羟的制备方法
DE102006034883A1 (de) * 2006-07-25 2008-01-31 Hermal Kurt Herrmann Gmbh & Co. Ohg Pharmazeutische Zusammensetzung enthaltend Mometasonfuroat
MX2009003100A (es) * 2006-09-22 2009-05-11 Ranbaxy Lab Ltd Inhibidores de fosfodiesterasa tipo iv.
US20100029728A1 (en) * 2006-09-22 2010-02-04 Ranbaxy Laboratories Limited Phosphodiesterase inhibitors
US20080207659A1 (en) * 2007-02-15 2008-08-28 Asit Kumar Chakraborti Inhibitors of phosphodiesterase type 4
US20110130403A1 (en) * 2007-03-14 2011-06-02 Ranbaxy Laboratories Limited Pyrazolo [3, 4-b] pyridine derivatives as phosphodiesterase inhibitors
PT2124944E (pt) * 2007-03-14 2012-05-17 Ranbaxy Lab Ltd Derivados de pirazolo[3,4-b]piridina como inibidores de fosfodiesterase
EP2111861A1 (en) 2008-04-21 2009-10-28 Ranbaxy Laboratories Limited Compositions of phosphodiesterase type IV inhibitors
AU2010253770B9 (en) 2009-05-29 2015-02-12 Pearl Therapeutics, Inc. Compositions for respiratory delivery of active agents and associated methods and systems
US8815258B2 (en) * 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
PT105058B (pt) 2010-04-21 2013-04-17 Hovione Farmaciencia S A Processo para processamento de partículas de ingredientes activos farmacêuticos
US20140275517A1 (en) 2013-03-15 2014-09-18 Pearl Therapeutics, Inc. Methods and systems for conditioning of particulate crystalline materials
CN107260671B (zh) * 2016-04-08 2021-03-26 天津金耀集团有限公司 一种糠酸莫米松混悬鼻喷剂组合物
CN107266518B (zh) * 2016-04-08 2021-03-30 天津金耀集团有限公司 一种糠酸莫米松晶型及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CY1359A (en) * 1981-02-02 1987-08-07 Schering Corp Aromatic heterocyclic esters of steroids, their preparation and pharmaceutical compositions containing them
US4783444A (en) 1984-09-17 1988-11-08 Schering Corporation Antiglaucoma compositions and methods
US4808610A (en) * 1986-10-02 1989-02-28 Schering Corporation Mometasone furoate anti-inflammatory cream composition using hexylene glycol
US4775529A (en) * 1987-05-21 1988-10-04 Schering Corporation Steroid lotion
PL165803B1 (pl) * 1990-09-10 1995-02-28 Schering Corp Sposób wytwarzania nowego monohydratu 9a, 21-dichloro-16-a metylo-1,4-pregnadieno-11 ß , 17a-diolo-3,20-diono-17-(2’furanokarboksylanu) PL PL PL PL

Also Published As

Publication number Publication date
MX9100990A (es) 1992-05-04
YU149791A (sh) 1994-01-20
DK0548114T5 (da) 1995-01-30
AU8497491A (en) 1992-03-30
HK185996A (en) 1996-10-11
NL980012I1 (nl) 1998-05-06
HRP920383B1 (en) 2000-04-30
SI9111497A (sl) 1998-04-30
MX9203396A (es) 1992-07-31
OA09772A (en) 1993-11-30
TW272195B (pt) 1996-03-11
IL99437A0 (en) 1992-08-18
HRP920383A2 (en) 1998-06-30
CZ281318B6 (cs) 1996-08-14
HUT64361A (en) 1993-12-28
NO930693D0 (no) 1993-02-26
BG60755B2 (bg) 1996-02-29
CZ38393A3 (en) 1994-01-19
CA2091360A1 (en) 1992-03-11
IE913155A1 (en) 1992-03-11
HU9300685D0 (en) 1993-06-28
ATE113604T1 (de) 1994-11-15
HU213401B (en) 1997-06-30
EE02962B1 (et) 1997-02-17
LU90366I2 (fr) 1999-05-05
ES2065701T3 (es) 1995-02-16
AU663471B2 (en) 1995-10-12
NO930693L (no) 1993-02-26
PL165803B1 (pl) 1995-02-28
EP0548114A1 (en) 1993-06-30
MY106644A (en) 1995-07-31
JPH05506667A (ja) 1993-09-30
FI931031A0 (fi) 1993-03-09
ZA917148B (en) 1992-08-26
DE19875032I2 (de) 2007-04-19
IE67056B1 (en) 1996-02-21
FI111078B (fi) 2003-05-30
CA2091360C (en) 1997-04-08
NL980012I2 (nl) 2004-11-01
NZ239711A (en) 1992-09-25
CN1030920C (zh) 1996-02-07
IL99437A (en) 1995-05-29
PH30443A (en) 1997-05-09
TW229208B (pt) 1994-09-01
NO300548B1 (no) 1997-06-16
EP0548114B1 (en) 1994-11-02
US6180781B1 (en) 2001-01-30
YU48666B (sh) 1999-06-15
DE69104991T2 (de) 1995-04-20
KR960013445B1 (ko) 1996-10-05
DE69104991D1 (de) 1994-12-08
PT98905B (pt) 1998-08-31
CN1059911A (zh) 1992-04-01
FI931031L (fi) 1993-03-09
WO1992004365A1 (en) 1992-03-19
JPH0725789B2 (ja) 1995-03-22

Similar Documents

Publication Publication Date Title
NL980012I2 (nl) Mometasonfuroaat-monohydraat, werkwijze om zulks te bereiden en farmaceutische samenstellingen.
PT99267A (pt) Processo para a preparacao de novos derivados de mercaptoacetilamida e de composicoes farmaceuticas que os contem
PT99671A (pt) Processo para a preparacao de heparosanos-n,o-sulfatados e de composicoes farmaceuticas que os contem
PT87880A (pt) Processo para a preparacao de composicoes farmaceuticas anti-virais que contem ciclo-dextrinas
BR1100850A (pt) Composto, processo para a preparação de um composto, e, composição farmacêutica
PT89094A (pt) Processo para a preparacao de 1-aril-3-quinolina-e 1-aril-3-isoquinolina-carboxamidas e de composicoes farmaceuticas que as contem
PT93094A (pt) Processo para a preparacao de 1,3-oxatiolanos substituidos e de composicoes farmaceuticas que os contem
PT96438A (pt) Processo para preparacao de anti-oxidante lipideo-selectivos e de composicoes farmaceuticas que os contem
MX9202748A (es) Compuesto de arileter, proceso para su obtencion y composicion farmaceutica que los contiene.
PT83909B (pt) Processo para a preparacao de 5-amino e 5-hidroxi-6,8-difluoroquinolonas e de composicoes farmaceuticas antibacterianas que as contem
PT92146A (pt) Processo para a preparacao do inibidor de glicosidade salbostatina e de composicoes farmaceuticas que a contem
MX9201295A (es) Derivados de benzofurano, proceso para su preparacion y composicion farmaceutica que los contienen.
IT1265101B1 (it) Derivati dell'acido 2-ammino-4-fenil-4-osso butirrico
MX9304793A (es) Glicanas de actividad inmunoestimulante.
MX9204031A (es) Sal de l-ascorbato de 16-descarboxi-16-hidroximetil-amfotericina b, proceso para su preparacion y composicion farmaceutica que contiene dicha sal.
AR002017A1 (es) Derivados de fenil-4-tiazoles substituidos, procedimiento para su preparacion, composiciones farmaceuticas que los contienen y derivados defenil-4-tiazoles substituidos empleados en dicho procedimiento.
PT99435A (pt) Processo para a preparacao de derivados de amino-sulfonil-ureia e de composicoes farmaceuticas que os contem
PT88201A (pt) Processo para a preparacao de um derivado de nitrometano e de composicoes farmaceuticas que o contem
ES2150461T3 (es) Derivados de amidinofenilalanina, proceso para su preparacion, su empleo y agentes que los contienen como anticoagulantes.
PT90787A (pt) Processo para a preparacao de 3-amino-sindnoniminas substituidas e de composicoes farmaceuticas que as contem
PT88074A (pt) Processo para a preparacao de antagonistas de leucotrieno e de composicoes farmaceuticas que os contem
PT99724A (pt) Processo para a preparacao de composicoes farmaceuticas que contem antigestogenios
PT88073A (pt) Processo para a preparacao de antagonistas de leucotrieno e de composicoes farmaceuticas que os contem
PT82257B (pt) Processo para a preparacao de 1,8-naftiridinonas substituidas e de composicoes farmaceuticas que as contem
PT90115A (pt) Processo para a preparacao de 2,6-metano-1,3-benzodiazocinas e de composicoes farmaceuticas que as contem

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19920427

FG3A Patent granted, date of granting

Effective date: 19980513

MM4A Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: MAXIMUM VALIDITY LIMIT REACHED

Effective date: 20130513